Referred to the House Health Care & Wellness Committee on January 9, 2017
Substitute offered in the House on February 15, 2017
Requires manufacturers that sell drugs into Washington to operate a drug take-back program to collect and dispose of prescription and over-the-counter drugs from residential sources.
Referred to the House Appropriations Committee on February 17, 2017
Amendment offered by Rep. Strom Peterson (Edmonds) (D) on February 9, 2018
Striker amendment. Requires manufacturers that sell drugs into Washington to operate a drug take-back program to collect and dispose of prescription and over-the-counter drugs from residential sources.
The amendment passed by voice vote in the House on February 9, 2018
Referred to the Senate Health & Long-Term Care Committee on February 13, 2018
Referred to the Senate Rules Committee on February 23, 2018
Amendment offered by Sen. Annette Cleveland (Vancouver) (D) on February 27, 2018
Clarifies that a qualifying nonprofit health care corporation is not considered a drug manufacturer for the purposes of the act if it only packages and supplies drugs to its facilities for clinical use.
The amendment passed by voice vote in the Senate on February 27, 2018